These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36918992)

  • 21. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Single-Case Reporting guideline In BEhavioural interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    J Sch Psychol; 2016 Jun; 56():133-42. PubMed ID: 27268573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extending the CONSORT Statement to moxibustion.
    Cheng CW; Fu SF; Zhou QH; Wu TX; Shang HC; Tang XD; Liu ZS; Liu J; Lin ZX; Lao L; Lü AP; Zhang BL; Liu BY; Bian ZX
    J Integr Med; 2013 Jan; 11(1):54-63. PubMed ID: 23464647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
    Lee H; Cashin AG; Lamb SE; Hopewell S; Vansteelandt S; VanderWeele TJ; MacKinnon DP; Mansell G; Collins GS; Golub RM; McAuley JH; ; Localio AR; van Amelsvoort L; Guallar E; Rijnhart J; Goldsmith K; Fairchild AJ; Lewis CC; Kamper SJ; Williams CM; Henschke N
    JAMA; 2021 Sep; 326(11):1045-1056. PubMed ID: 34546296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.
    Hopewell S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF;
    PLoS Med; 2008 Jan; 5(1):e20. PubMed ID: 18215107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].
    Hopewel S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF; The CG
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):221-32. PubMed ID: 18334138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension.
    Liu X; Rivera SC; Moher D; Calvert MJ; Denniston AK;
    BMJ; 2020 Sep; 370():m3164. PubMed ID: 32909959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Evid Based Commun Assess Interv; 2016 Jan; 10(1):44-58. PubMed ID: 27499802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
    Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
    BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol for the development of consensus-based clinical case reporting guideline extension: CARE for acupuncture.
    Duan Y; Chen Y; Chen J; Chen Z; Riley D; Xu N; Zheng Y; Wang Q; Deng J; Lu L; Tang C
    Complement Ther Med; 2019 Aug; 45():185-189. PubMed ID: 31331558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
    Liu X; Cruz Rivera S; Moher D; Calvert MJ; Denniston AK;
    Nat Med; 2020 Sep; 26(9):1364-1374. PubMed ID: 32908283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the quality of reporting acupuncture interventions: describing the collaboration between STRICTA, CONSORT and the Chinese Cochrane Centre.
    MacPherson H; Altman DG
    J Evid Based Med; 2009 Feb; 2(1):57-60. PubMed ID: 21348986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
    Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.